This invention relates to an ingestible drug delivery device configured for wireless communication with other ingestible drug delivery devices.

A device for producing and/or storing electrical energy (2), characterized in that the device comprises: an anode (4), a cathode (6), a separator (8) allowing for the transfer of at least one compound capable of triggering and/or enabling a production and/or storage of electrical energy (8), arranged between the anode (4) and the cathode (6), and at least one breakable, pierceable, and/or deformable reservoir (10) made of a compound capable of triggering and/or enabling a production and/or a storage of electrical energy, said reservoir (10) having means for bringing said compound and said separator (8) into contact with each other; said means for bringing said compound and said separator (8) into contact with each other being, in particular, means for transferring a liquid.

A health care system includes a server to provide a service to care for a health state of each user, and a terminal of each user. The server registers and manages user information containing at least attribute information of the user, health information, or action information as share information of a group of users in response to an operation from the terminal of the user, checks similarity between the users in the share information, determines a similar user of each of the users, and outputs share information of the similar user of the user to the terminal of the user on the basis of the check information. The health information contains time series data of one element of measurement items containing a body temperature of the user, menstruation, examination results, medication, or symptoms. The action information contains time series data of one of actions or arbitrary texts.

Medical implants including sensors are described. The implant may have a flexible shell with a base, wherein the plurality of sensors may be incorporated onto and/or into the shell. The plurality of sensors may be distributed at different locations of the shell. Each sensor of the plurality of sensors may be configured to measure one or more parameters such as, e.g., temperature and/or pressure, and may comprise an electromagnetic coil useful for wireless transmission of data. Each sensor may be configured to transmit data at a frequency different from the frequency of one or more of the other sensors, may be configured to transmit data at a time different from a time data is transmitted by one or more of the other sensors, and/or may include a device identifier different from the device identifier of one or more of the other sensors.

A maternal and fetal monitoring device using multiple sensing units is disclosed. The maternal and fetal monitoring device comprises: a processor module and a plurality of sensor modules, wherein each said sensor module comprises: an inertial sensor, a temperature sensor and a first acoustic sensor. After being attached onto a maternal body, each said sensor module collects a body temperature signal, an inertia signal and a sound signal. Subsequently, the processor module determines a maternal body posture by analyzing the inertia signal, determines a maternal physical condition and a fetal physical condition by analyzing the inertial signal, the plurality of first sound signals and the second sound signal, and estimates physiological parameters of the maternal body and a fetus by analyzing the body temperature sensing signal, the plurality of first sound signals, and the second sound signals.

A method of early detection of risk of pre-eclampsia in a pregnant woman comprises the steps of determining the blood pressure and body mass index (BMI) of the pregnant woman, and optionally sex of the fetus, at 8 to 24 weeks of pregnancy, comparing the BMI with a reference BMI, and comparing the blood pressure input with a reference blood pressure, and providing a risk of pre-eclampsia and in particular term or pre-term pre-eclampsia based on the comparison.

A system and method are provided for collection and testing of a biologic sample in a self-diagnostic test. The system and method comprise collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects include a mobile application operating on a mobile device with which the user interacts. These aspects allow advertisements and other messages to be presented to the user through the mobile application. Some aspects present different messages to the user based on the type of self-diagnostic test the user is conducting.

This invention relates to an ingestible drug delivery device configured for wireless communication with other ingestible drug delivery devices.

A device for detecting postpartum hemorrhage is provided. A mat defines a proximal end and a distal end. The mat is configured to be disposed between a support and a patient and has a surface with a fluid flow region configured to direct flow of bodily fluids from the patient towards the distal end of the mat. A first detachable and optionally sealable bag is configured to receive the bodily fluids from the patient in a first operational mode of the device. A second sealable bag is configured to receive the bodily fluids from the patient in a second operational mode of the device. The second sealable bag comprises a visual volume indicator to measure the bodily fluids collected in the second sealable bag.

A computer-implemented system and method are for alerting an expectant mother to a medical risk during pregnancy. A profile of the expectant mother is used, and reports are received from the expectant mother identifying experienced symptoms. In response to a report at a particular time, any reports received over a subsequent time window are monitored, and based on the combination of reports received during the time window and the profile of the expectant mother, the need for a risk alert is determined. The user is more willing to report symptoms, because a risk alert (which functions as reporting symptoms to a medical expert) only takes place when a real risk is identified.